Clinical Trials at Centro Oncologico Estatal ISSEMYM
During the past decade, Centro Oncologico Estatal ISSEMYM conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 6 clinical trials were completed, i.e. on
average, 120% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer
2009-05-01
2018-02-01
Completed
1,613
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Centro Oncologico Estatal ISSEMYM" #1 sponsor was "Hoffmann-La Roche" with 7 trials, followed by "Aragon Pharmaceuticals, Inc." with 1 trials
sponsored, "Boehringer Ingelheim" with 1 trials sponsored, "EMD Serono Research & Development Institute, Inc." with 1 trials sponsored and "Genentech, Inc."
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Centro Oncologico Estatal ISSEMYM"
#1 collaborator was "Foundation Medicine, Inc." with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator, "Hoffmann-La Roche" with 1 trials as a collaborator, "Latin American Cooperative Oncology Group" with 1 trials as a collaborator and "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were
collaborators in the rest 5 trials.
Clinical Trials Conditions at Centro Oncologico Estatal ISSEMYM
According to Clinical.Site data, the most researched conditions in "Centro Oncologico Estatal ISSEMYM" are
"Breast Cancer" (4 trials), "Cancer of Unknown Primary Site" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials), "Cervical Cancer" (1 trials) and "Mesothelioma" (1 trials). Many other conditions were trialed in "Centro Oncologico Estatal ISSEMYM" in a lesser frequency.
Clinical Trials Intervention Types at Centro Oncologico Estatal ISSEMYM
Most popular intervention types in "Centro Oncologico Estatal ISSEMYM" are "Drug" (11 trials). Other intervention types were less common.
The name of intervention was led by "Bevacizumab" (4 trials), "Pertuzumab" (4 trials), "Docetaxel" (3 trials), "Trastuzumab" (3 trials) and "Atezolizumab" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Centro Oncologico Estatal ISSEMYM
The vast majority of trials in "Centro Oncologico Estatal ISSEMYM" are
7 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at Centro Oncologico Estatal ISSEMYM
Currently, there are NaN active trials in "Centro Oncologico Estatal ISSEMYM".
undefined are not yet recruiting,
undefined are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 7 completed trials in Centro Oncologico Estatal ISSEMYM,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Centro Oncologico Estatal ISSEMYM, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 7 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".